Results 161 to 170 of about 285,971 (306)

Experience and practices of doctors towards pharmacist medication reconciliation service in medical wards: a multicentre study in Perak state Malaysia. [PDF]

J Pharm Policy Pract
Kamaludin RS, Chee Tao C, Hoey Lin O, Pooi Yee C, Wen Yan T, Wei Yee C, Ling Wei N, Lee Rhui T.   +7 more
europepmc   +1 more source

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients

British Journal of Clinical Pharmacology, EarlyView.
Aim Enoxaparin dosing in burn patients is challenging due to physiological changes affecting absorption, distribution and clearance. The objectives of this study are to develop a population pharmacokinetic (PK) model for enoxaparin in burn patients, evaluate target attainment with current equation‐based (EQ) dosing and propose an optimized dosing ...
Babajide Shenkoya, Venkata Yellepeddi, Ann Marie B. Prazak, Mathangi Gopalakrishnan   +3 more
wiley   +1 more source

A national pilot community pharmacy-led urinary tract infection service: clinical and patient-reported outcomes from 9077 consultations. [PDF]

J Antimicrob Chemother
Mantzourani E, Ahmed H, Evans A, Macdonald S, Lintern G, Phyfer R, Davies M, Cannings-John R.   +7 more
europepmc   +1 more source

N‐of‐1 trials in clinical research: Methodological foundations, statistical approaches and implementation challenges

British Journal of Clinical Pharmacology, EarlyView.
N‐of‐1 trials offer a unique and rigorous methodology for evaluating individualized treatment responses, particularly within the context of personalized medicine. This article provides a comprehensive explanation of the conceptual and methodological underpinnings of N‐of‐1 trials, with particular emphasis on statistical techniques and considerations ...
Marcos Clint Leal De Carvalho, Matheus de Matos Dourado Simões, Ubiratan Cardinalli Adler, Antonio Brazil Viana Junior, Caren Nádia Soares de Sousa, Lia Lira Olivier Sanders   +5 more
wiley   +1 more source

Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience. [PDF]

Front Pharmacol
Mengato D, Camuffo L, Todino F, Cordiano L, Condello D, Bucciol C, Benini F, Russo FP, Cipriani A, Sartori S, Sarzo G, Tessarin M, Venturini F.   +12 more
europepmc   +1 more source

Drug poisonings following bariatric surgery: Case series report

British Journal of Clinical Pharmacology, EarlyView.
Bariatric surgery alters gastrointestinal anatomy and physiology, which likely impacts upon oral medication absorption. Drug‐ and alcohol‐related deaths in this population are being increasingly reported; however, toxicological detail is lacking. Using data reported to the National Programme on Substance Use Mortality, we identified 18 deaths in people
Eman Mshari, Fannie LaJeunesse‐Trempe, Stephen Morley, Caroline Copeland   +3 more
wiley   +1 more source

Interprofessional Collaboration Between Community Health Workers and Pharmacists. [PDF]

Health Expect
Bandiera C, Darwood M, Mistry SK, Harris E, Harris MF, Aslani P.   +5 more
europepmc   +1 more source

Penicillin allergy de‐labelling in the critical care unit: Simulations to design an intravenous drug provocation test that mirrors the plasma profile of an enteral challenge

British Journal of Clinical Pharmacology, EarlyView.
The majority of penicillin allergy labels are incorrect and a label of penicillin allergy is associated with worse outcomes and increased use of healthcare services. Penicillin allergy assessment and de‐labelling may be considered in critically ill patients. An oral penicillin challenge is a common component of most penicillin allergy protocols.
Cleodie Swire, Sean Keane, Reya Vinay Shah, Toqa El‐Nahhas, Iao Lei, Salma Alamin, Niall Conlon, Dagan Osborne Lonsdale   +7 more
wiley   +1 more source

A data-driven approach to optimizing waiting times in outpatient pharmacy services: Interrupted time series analysis. [PDF]

Explor Res Clin Soc Pharm
Alghamdi H, Alshihayb TS, Alharbi Y, Alawagi M, Aleissa A, Albogami Y.   +5 more
europepmc   +1 more source

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of life‐threatening gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. A recent UK‐wide survey of local hospital protocols for the use of andexanet alfa suggested that practice ...
Louis Fisher, Richard Buka, Rosalind Byrne, Stephen Black, Helen J. Curtis, Christopher Wood, Andrew Brown, Sebastian Bacon, Richard Croker, Ben Goldacre, Brian MacKenna, Victoria Speed   +11 more
wiley   +1 more source